Cidara Therapeutics Receives $42,000,000 Series B Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0f76b47d-9879-4c5b-956a-3ca1330d86dd
Date
2/11/2015
Company Name
Cidara Therapeutics
Mailing Address
6310 Nancy Ridge Drive San Diego, CA 92121 USA
Company Description
Our vision is to apply the versatile Cloudbreak small molecule immunotherapy platform to treat patients with compromised immune systems across multiple therapeutic areas.
Website
http://www.cidara.com
Transaction Type
Venture Equity
Transaction Amount
$42,000,000
Transaction Round
Series B
Proceeds Purposes
Proceeds from the financing will enable us to accelerate the development of our echinocandin antifungal programs, biafungin and topifungin, as well as our immunotherapy platform, Cloudbreak, which, we believe, may represent a fundamentally new approach to the treatment of infectious diseases.
M&A Terms
Venture Investor